CDC panel votes to revoke new child hepatitis B vaccine suggestion
The CDC’s resolution marks the company’s first change in suggestion associated to hepatitis B prevention in additional than three a...
Pharmaceutical Updates
Merck suffers a setback over Keytruda formulation in Germany
In a setback for Merck, a German courtroom issued a preliminary injunction that stops the corporate from distributing a brand...
Job Postings in November Tick Up–However So Do Functions
In key biopharma disciplines, together with analysis and improvement, scientific, manufacturing and manufacturing and gross sales and repair, stay job...
Richard Padzur to depart FDA following current CDER management shift
CDER director Richard Padzur has handed in his retirement papers after beneath a month in his new place on the...
High drug regulator Richard Pazdur set to depart the FDA
WASHINGTON — High drug regulator Richard Pazdur has filed papers to retire from the Meals and Drug Administration on the...
Biotechs Safe Various Fill/End Capability Amid Scrutiny of Novo Web site
A method or one other, firms derailed by high quality issues at a Novo Nordisk plant are edging towards options....
Eisai seeks PMDA approval for subcutaneous Leqembi in Japan
The formulation will function a brand new administration route. Credit score: Dragana Gordic/Shutterstock.com. Eisai has submitted a brand new drug...
FDA approves Otsuka remedy to deal with autoimmune kidney illness
Adam Feuerstein is a senior author and biotech columnist, reporting on the crossroads of drug improvement, enterprise, Wall Road, and...
Novo’s GLP-1s Spotlight Listing as CMS Unveils Remaining Costs For Second Cycle of Drug Negotiations
Negotiations for the second cycle of the Inflation Discount Act’s drug pricing program have wrapped up, and the Facilities for...
Celltrion secures Well being Canada go-ahead for Eylea biosimilar
Celltrion’s Eylea biosimilar, Eydenzelt, has gained approval from Well being Canada, making it the fifth Eylea biosimilar to be accessible...
We’re studying about Medicare drug costs, FDA voucher program
Completely satisfied Thanksgiving Eve, Pharmalittle readers. That is Allison, filling in for Mr. Pharmalot. I lately hosted a mini Thanksgiving...
Otsuka Secures IgAN Win as FDA Approves First Anti-APRIL Antibody
The FDA has granted accelerated approval to Otsuka’s anti-APRIL antibody sibeprenlimab to scale back urine protein ranges in sufferers with...
SK bolsters oncology pipeline in radiopharmaceutical licensing deal
SK Biopharmaceuticals has licensed the worldwide improvement, manufacturing and commercialisation rights to preclinical radiopharmaceutical asset, WT-7695, from a US-based educational...
Sarepta Duchenne drug, Otsuka, Prasad, Medicare: The Readout
Wish to keep on high of the science and politics driving biotech right this moment? Join to get our biotech e-newsletter in...
Price range Cuts Are Hobbling American Innovation
The world’s strongest early-stage innovation incubator is faltering. For many years, U.S. federal grants and Small Enterprise Innovation Analysis (SBIR)...
